China National Pharmaceutical Group Corporation

URI: https://gptkb.org/entity/China_National_Pharmaceutical_Group_Corporation
GPTKB entity
Statements (33)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkb:state-owned_enterprise
gptkbp:affiliatedWith gptkb:Sinopharm_Dongfeng_General_Hospital
gptkb:Sinopharm_Tongjitang_Hospital
gptkbp:alsoKnownAs gptkb:Sinopharm
gptkbp:country gptkb:China
gptkbp:founded 1998
gptkbp:headquartersLocation gptkb:Beijing,_China
https://www.w3.org/2000/01/rdf-schema#label China National Pharmaceutical Group Corporation
gptkbp:industry healthcare
pharmaceuticals
gptkbp:keyPerson gptkb:Liu_Jingzhen
gptkbp:notableProduct gptkb:Sinopharm_BIBP_COVID-19_vaccine
gptkb:Sinopharm_WIBP_COVID-19_vaccine
gptkbp:numberOfEmployees over 100,000
gptkbp:parentOrganization gptkb:State-owned_Assets_Supervision_and_Administration_Commission_of_the_State_Council
gptkbp:products pharmaceuticals
medical devices
vaccines
healthcare services
gptkbp:rank gptkb:Fortune_Global_500
gptkbp:researchInterest gptkb:traditional_medicine
vaccine development
biopharmaceuticals
gptkbp:revenue over 500 billion RMB (2022)
gptkbp:servesArea worldwide
gptkbp:stockExchange Hong Kong Stock Exchange (via Sinopharm Group)
gptkbp:subsidiary gptkb:Sinopharm_Group
gptkb:China_National_Pharmaceutical_Foreign_Trade_Corporation
gptkb:China_National_Medicines_Corporation
gptkbp:website http://www.sinopharm.com/
gptkbp:bfsParent gptkb:Sinopharm
gptkbp:bfsLayer 5